Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 6/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1514827 | 0.89 | TDP1 (0.64) | TDP1TP53SMN1; SMN2POLBALDH1A1 | |
| SCHEMBL17622466 | 0.84 | KMT2A (0.80) | TDP1TP53SMN1; SMN2POLBALDH1A1 | |
| SCHEMBL17622805 | 0.83 | TDP1 (0.65) | TDP1TP53POLBALDH1A1HPGD | |
| SCHEMBL16264771 | 0.81 | TDP1 (0.65) | TDP1SMN1; SMN2POLBALDH1A1HPGD | |
| SCHEMBL16264706 | 0.80 | MEN1 (0.80) | TDP1TP53SMN1; SMN2POLBALDH1A1 | |
| SCHEMBL17603619 | 0.80 | MEN1 (0.45) | TDP1TP53SMN1; SMN2POLBALDH1A1 | |
| SCHEMBL17603597 | 0.79 | MEN1 (0.44) | TDP1TP53SMN1; SMN2POLBALDH1A1 | |
| SCHEMBL17622804 | 0.79 | TDP1 (0.67) | TDP1SMN1; SMN2POLBALDH1A1HPGD | |
| SCHEMBL17622906 | 0.78 | ALDH1A1 (1.00) | TDP1SMN1; SMN2ALDH1A1HPGDMEN1 | |
| SCHEMBL7465822 | 0.78 | ALDH1A1 (0.60) | TDP1TP53SMN1; SMN2POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3000807-B1 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | ACAD OF MILITARY MEDICAL SCIENCES (CN) | 2021-04-21 | — | — | EP | disclosed |
| US-10035771-B2 | Mercaptonicotinic acid compound and preparation method and use thereof | INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, PR CHINA (CN) | 2018-07-31 | — | — | US | disclosed |
| EP-3000807-A1 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, PR China (CN) | 2016-03-30 | — | — | EP | disclosed |
| US-20160083347-A1 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, PR CHINA (CN) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083347-A1 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | PREP, ENGASE, ADAMTS13 | TDP1 2036/4885TP53 4399/4885SMN1; SMN2 1053/4885 |
| US-10035771-B2 | Mercaptonicotinic acid compound and preparation method and use thereof | PREP, ENGASE, ADAMTS13 | TDP1 2036/4885TP53 4399/4885SMN1; SMN2 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.